Structural models for the complex of chemotaxis inhibitory protein of Staphylococcus aureus with the C5a receptor

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 481-484

  Nikiforovich, Gregory V ^a   Baranski, Thomas J ^b  

^a MolLife Design LLC   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C5a receptor; Chemotaxis inhibitory protein; GPCRs; Molecular modeling

Indexed keywords

CHEMOTAXIS INHIBITOR; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR;

ARTICLE; BINDING SITE; MOLECULAR MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; STAPHYLOCOCCUS AUREUS;

BACTERIAL PROTEINS; CHEMOTAXIS; COMPUTER SIMULATION; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN CONFORMATION; RECEPTOR, ANAPHYLATOXIN C5A; STAPHYLOCOCCUS AUREUS;

STAPHYLOCOCCUS AUREUS;

EID: 70449701449     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.113     Document Type: Article

References (17)

1. de Haas C.J., Veldkamp K.E., Peschel A., Weerkamp F., Van Wamel W.J., Heezius E.C., Poppelier M.J., Van Kessel K.P., and van Strijp J.A. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. Journal of Experimental Medicine 199 (2004) 687-695
2. Postma B., Poppelier M.J., van Galen J.C., Prossnitz E.R., van Strijp J.A., de Haas C.J., and van Kessel K.P. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. Journal of Immunology 172 (2004) 6994-7001
3. Haas P.J., de Haas C.J., Kleibeuker W., Poppelier M.J., van Kessel K.P., Kruijtzer J.A., Liskamp R.M., and van Strijp J.A. N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor. Journal of Immunology 173 (2004) 5704-5711
4. Haas P.J., de Haas C.J., Poppelier M.J., van Kessel K.P., van Strijp J.A., Dijkstra K., Scheek R.M., Fan H., Kruijtzer J.A., Liskamp R.M., and Kemmink J. The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules. Journal of Molecular Biology 353 (2005) 859-872
5. Gustafsson E., Haas P.J., Walse B., Hijnen M., Furebring C., Ohlin M., van Strijp J.A., and van Kessel K.P. Identification of conformational epitopes for human IgG on chemotaxis inhibitory protein of Staphylococcus aureus. BMC Immunology 10 (2009) 13
6. Mollison K.W., Mandecki W., Zuiderweg E.R., Fayer L., Fey T.A., Krause R.A., Conway R.G., Miller L., Edalji R.P., and Shallcross M.A. Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis. Proceedings of the National Academy of Sciences of the United States of America 86 (1989) 292-296
7. Siciliano S.J., Rollins T.E., DeMartino J., Konteatis Z., Malkowitz L., Van Riper G., Bondy S., Rosen H., and Springer M.S. Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. Proceedings of the National Academy of Sciences of the United States of America 91 (1994) 1214-1218
8. DeMartino J.A., Van Riper G., Siciliano S.J., Molineaux C.J., Konteatis Z.D., Rosen H., and Springer M.S. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs. Journal of Biological Chemistry 269 (1994) 14446-14450
9. Postma B., Kleibeuker W., Poppelier M.J., Boonstra M., Van Kessel K.P., Van Strijp J.A., and de Haas C.J. Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus. Journal of Biological Chemistry 280 (2005) 2020-2027
10. Ippel J.H., de Haas C.L.C., Bunschoten A., van Strijp J.A.G., Kruijtzer J.A.W., Liskamp R.M.J., and Kemmink J. Structure of the tyrosine-sulfated C5a receptor N terminus in complex with chemotaxis inhibitory protein of Staphylococcus aureus. Journal of Biological Chemistry 284 (2009) 12363-12372
11. Nikiforovich G.V., Marshall G.R., and Baranski T.J. Modeling molecular mechanisms of binding of the anaphylotoxin C5a to the C5a receptor. Biochemistry 47 (2008) 3117-3130
12. Hagemann I.S., Miller D.L., Klco J.M., Nikiforovich G.V., and Baranski T.J. Structure of the complement factor 5a receptor-ligand complex studied by disulfide trapping and molecular modeling. Journal of Biological Chemistry 283 (2008) 7763-7775
13. Dunfield L.G., Burgess A.W., and Scheraga H.A. Energy parameters in polypeptides. 8. Empirical potential energy algorithm for the conformational analysis of large molecules. Journal of Physical Chemistry 82 (1978) 2609-2616
14. Nemethy G., Pottle M.S., and Scheraga H.A. Energy parameters in polypeptides. 9. Updating of geometrical parameters, nonbonded interactions, and hydrogen bond interactions for the naturally occurring amino acids. Journal of Physical Chemistry 87 (1983) 1883-1887
15. Nikiforovich G.V., Hruby V.J., Prakash O., and Gehrig C.A. Topographical requirements for delta-selective opioid peptides. Biopolymers 31 (1991) 941-955
16. 1 receptor. Journal of Peptide Research 66 (2005) 236-248
17. Wright A.J., Higginbottom A., Philippe D., Upadhyay A., Bagby S., Read R.C., Monk P.N., and Partridge L.J. Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response. Molecular Immunology 44 (2007) 2507-2517